Compare ClearPoint Neuro Inc (CLPT) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs Citius Pharmaceuticals Inc — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: ClearPoint Neuro Inc is far larger — about 22.7× Citius Pharmaceuticals Inc's market cap, and ClearPoint Neuro Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | CTXR | |
|---|---|---|
Market Cap | $454.21M | $20.01M |
Sector | Health | Health |
52-Week High | $29.60 | $1.82 |
52-Week Low | $8.66 | $0.48 |
Enterprise Value | $488.79M | $16.23M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
